ICL Israel Chemicals Ltd (ICL)
Official siteBASIC MATERIALS • AGRICULTURAL INPUTS • NYSE
Market Cap: $6.03B
Last updated: Nov 17, 2026 at 11:06 AM ET
ICL Israel Chemicals Ltd (ICL) Stock Forecast
Analysts expect ICL Israel Chemicals (ICL) to earn $0.41 per share in the fiscal year ending Dec 31, 2026, on revenue of $7.95B. Of 4 analysts, 0 rate the stock Buy or Strong Buy, 4 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 3 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 3.00, inside the Hold band from 2.5 up to 3.5. All 4 rate it Hold.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 0 | 0.0% |
| Hold | 4 | 100.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 7.3% and revenue estimates rise 2.9%.
- Fiscal year ending Dec 31, 2026
- $0.41
- EPS consensus, revenue $7.95B
- Fiscal year ending Dec 31, 2027
- $0.44
- EPS consensus, revenue $8.18B
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.41 | $0.40 to $0.41 | 2 | $7.95B | $7.65B to $8.25B | 4 |
| Dec 31, 2027 | $0.44 | $0.40 to $0.46 | 4 | $8.18B | $7.99B to $8.45B | 4 |
Quarterly Estimates
The EPS consensus rises from $0.09 for the quarter ending Dec 31, 2026 to $0.11 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | $0.09 | $0.09 to $0.09 | 3 |
| Mar 31, 2027 | $0.11 | $0.10 to $0.12 | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 6 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 3 |
| Fiscal year ending Dec 31, 2027 | 0 | 2 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 4.7% from $0.43.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.41 | $0.41 | $0.42 | $0.43 | $0.43 | -5.0% |
| Fiscal year ending Dec 31, 2027 | $0.44 | $0.43 | $0.44 | $0.44 | $0.44 | +0.5% |
| Quarter ending Mar 31, 2027 | $0.11 | $0.11 | $0.11 | $0.11 | $0.12 | -10.4% |
Frequently Asked Questions About ICL
What is the ICL stock forecast?
Consensus analyst estimates put ICL Israel Chemicals's EPS at $0.41 for the fiscal year ending Dec 31, 2026, on revenue of $7.95B. The consensus rating from 4 analysts is Hold.
How do analysts rate ICL stock?
Of 4 analysts covering ICL Israel Chemicals, 0 rate it Strong Buy, 0 Buy, 4 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from ICL next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.41, with estimates from $0.40 to $0.41 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.44, with estimates from $0.40 to $0.46 from 4 analysts.
What revenue do analysts expect from ICL Israel Chemicals next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $7.95B, with estimates from $7.65B to $8.25B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $8.18B, with estimates from $7.99B to $8.45B.
How many analysts cover ICL?
4 analysts rate ICL Israel Chemicals stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
ICL pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors